It has been reported that HAT1 upregulated in hepatocellular carcinoma (HCC) facilitated HCC cell growth, and its knockdown could sensitize HCC cells to cisplatin-induced apoptosis [216]. Here, HAT1 is linked to hepatocellular carcinoma.